Anthem Biosciences IPO listing was in line with the Street estimates as indicated by the grey market premium (GMP). Anthem ...

Anthem Biosciences Limited has made an initial public offering of equity shares aggregating to ₹3,395 crore. Trilegal ...

Anthem Biosciences IPO listing date is today. Ahead of the listing, Anthem Biosciences IPO GMP today and analysts signal a ...

Anthem Biosciences shares listed at ₹723.10 per share on the BSE and ₹723.05 per share on the NSE, compared to the issue ...

Anthem’s IPO did not include a fresh issue, with all proceeds going to existing shareholders. Prior to the IPO opening, ...

Anthem Biosciences share price on the BSE was trading at Rs. 730.70, up Rs. 7.60 or 1.05% from the listing price and a 28.19% ...

Anthem Biosciences Ltd ended its debut trading day with a premium of over 28%. Despite the high opening figures, the company ...

Contract research, development, and manufacturing organisation Anthem Biosciences shares recorded healthy returns on its ...

Ahead of its listing, Anthem Biosciences was commanding a strong grey market premium (GMP) of ₹179 in the unlisted market, ...

Anthem Biosciences shares listed at a healthy premium on Monday, following a bumper subscription of about 64 times to its Rs 3,395-crore public issue.

Analysts said that Anthem Biosciences' IPO was fairly priced, supported by strong growth, industry-leading margins, and ...

Anthem Biosciences, a leading contract research and manufacturing organization (CRDMO), made a strong debut on the Indian ...